Evaluation of the p53 pathway in polycystic ovarian syndrome pathogenesis and apoptosis enhancement in human granulosa cells through transcriptome data analysis von Zanjirband, M., Hodayi, R., Safaeinejad, Z., Nasr-Esfahani, M. H., Ghaedi-Heydari, R.

Volltext

Transcriptomic screening to identify hub genes and drug signatures for PCOS based on RNA-Seq data in granulosa cells von Zanjirband, M., Baharlooie, M., Safaeinejad, Z., Nasr-Esfahani, M.H.

Volltext

A Systematic Review of the Molecular Mechanisms Involved in the Association Between PCOS and Endometrial and Ovarian Cancers von Zanjirband, M., Nasr‐Esfahani, M. H., Curtin, N. J., Drew, Y., Sharma Saha, S., Adibi, P., Lunec, J.

Volltext

55P Evaluation of MDM2-p53 antagonists, nutlin-3 and RG7388, combined with the PARPi rucaparib in primary cultures of ovarian cancer von Zanjirband, M., Gentles, L., Curtin, N.J., O'Donnell, R.L., Lunec, J.

Volltext

Abstract P3-07-21: Cytotoxic potential of the RG7388 MDM2-p53 binding antagonist and the GSK2830371 WIP1 inhibitor on MX-1 and MCF-7 human breast cancer cells von Manoharan, V, Lunec, J, Esfandiari, A, Mahdi, A, Wu, C-E, Zanjirband, M, Karunanayake, EH, Tennekoon, KH, De Silva, S

Volltext

Diversity of produced extra cellular hydrolytic enzymes by Halomonas strains von Zanjirband, M., Kermanshahi, R.K., Golbang, N.

Volltext